Tissue Engineering And Nanotheranostics

(Steven Felgate) #1

“9.61x6.69” b2815 Tissue Engineering and Nanotheranostics


Multifunctional Nanomaterials for Cancer Theranostics 235

2.2. Liposome


The liposome with its capacity to self­assemble into a bilayer structure


is composed of both hydrophobic and hydrophilic component, is the


most widely used for targeted drug delivery.^1 21–124 The lipid bilayer can


be composed of cationic, anionic, or neutral (phospho)lipids and cho­


lesterol. To improve liposome stability and enhance their circulation


times in the blood, some hydrophilic polymers, such as PEG are often


chosen for obtaining sterically­stabilized liposome.125,126 Its unique


structure gives the liposome a powerful drug loading function.


Hydrophobic drugs can be inserted into the bilayer membrane, with


the hydrophilic molecules trapped in the aqueous center. Moreover,


owing to the large aqueous center and biocompatible lipid exterior, a


variety of macromolecules, such as DNA, proteins and imaging agents


can also be delivered by means of the liposome. The use of the


liposomes as drug vesicles have been shown to be beneficial for stabi­


lizing therapeutic drugs, overcoming obstacles to cellular and tissue


uptake, and improving biodistribution of drug. Moreover, the


liposomes are biocompatible, their surface properties can be easily


modified according to the need of active targeting to tumor site, and


their particle sizes can be precisely controlled. Despite these advan­


tages, the liposome nanocarriers also have shortcomings, including


poor stability, low loading efficiency, and poor release profiles.


2.3. Dendrimers


Dendrimers are constituted of successive branched layers with dis­


crete, highly compact and tree­like nanostructures. Their size is well


controlled with the increase of the dendrimer generation. Dendrimers


as drug carriers also possess a lot of advantages.^127 For instance,


because of the excellent monodispersity, the dendrimers loaded anti­


cancer drugs provide a good promise for reproducible pharmacody­


namic and pharmacokinetic behaviors.^128 The nanosize and unique


structure of dendrimers ensure drug delivery applications in vivo.129,130


The sufficient functional groups on the surface of dendrimers can be


modified with various ligands such as targeting moieties, imaging

Free download pdf